Inventor · Meyzieu, FR

Olivier Soula

34Patents
8h-index
26Co-inventors
75Inventor score

Filing activity: Jul 29, 1998 → Feb 20, 2018

Most-cited inventions

PatentTitleAreaCited byStatus
US8679540B2 Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications Human Necessities 52 Active
US8084045B2 Pharmaceutical formulations for the prolonged release of active principle(s) and their applications Human Necessities 35 Active
USRE46686E1 Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications General 34 Active
US6133199A Process and compositions promoting biological effectiveness of exogenous chemical substances in plants Human Necessities 22 Expired
US8241620B2 Complex polymere amphiphile-PDGF Human Necessities 13 Active
US9457089B2 Highly concentrated aqueous protein solution with reduced viscosity Human Necessities 13 Active
US6500783B1 Process and compositions promoting biological effectiveness of exogenous chemical substances in plants Human Necessities 12 Expired
US9493583B2 Anionic polysaccharides functionalized by a hydrophobic acid derivative Chemistry; Metallurgy 8 Active
US9089476B2 Injectable solution at pH 7 comprising at least one basal insulin whose PI is between 5.8 and 8.5 Human Necessities 8 Active
US8426382B2 Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivative Chemistry; Metallurgy 4 Active
US9492467B2 Rapid-acting insulin formulation comprising an oligosaccharide Human Necessities 3 Active
US9795678B2 Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound Chemistry; Metallurgy 3 Active
US9700599B2 Rapid-acting insulin formulation comprising a substituted anionic compound Chemistry; Metallurgy 3 Active
US10485851B2 Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid Human Necessities 2 Active
US10548952B2 Injectable solution at pH7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5, a prandial insulin and/or a gastrointestinal hormone, and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals Human Necessities 2 Active
US10383918B2 Compositions in the form of an injectable aqueous solution comprising human glucagon and a statistical co-polyamino acid Human Necessities 2 Active
US10583175B2 Rapid-acting insulin formulation comprising a substituted anionic compound Chemistry; Metallurgy 2 Active
US10383920B2 Injectable solution at pH 7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals Human Necessities 2 Active
US9233993B2 N-phosphonomethylglycine guanidine derivative salts Chemistry; Metallurgy 1 Active
US9018190B2 Functionalized oligosaccharides Chemistry; Metallurgy 1 Active
US8389661B2 Complexes between an amphiphilic polymer and an osteogenic protein belonging to the family of BMPs Chemistry; Metallurgy 1 Active
US10792335B2 Rapid-acting insulin composition comprising a substituted citrate Human Necessities 1 Active
US8546356B2 Administration form of osteogenic protein complexes Human Necessities 1 Active
US8367640B2 Complex consisted of a polysaccharide and an HBP Human Necessities 1 Active
US8293255B2 Polyglutamic acids functionalised by histidine derivatives and hydrophobic groups and the uses thereof, in particular for therapeutic purposes Human Necessities 1 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.